Retatrutide, a novel dual stimulator of the GLP-1 receptor and glucose-dependent released polypeptide (GIP) binding site , is showing promising data in preliminary human trials . Ongoing research suggests https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/